BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1322 related articles for article (PubMed ID: 28881918)

  • 1. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

  • 2. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Vansteenkiste J; De Ruysscher D; Eberhardt WE; Lim E; Senan S; Felip E; Peters S;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi89-98. PubMed ID: 23860613
    [No Abstract]   [Full Text] [Related]  

  • 3. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Crinò L; Weder W; van Meerbeeck J; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v103-15. PubMed ID: 20555058
    [No Abstract]   [Full Text] [Related]  

  • 4. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
    Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
    Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-small cell lung cancer. Clinical practice guidelines in oncology.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Mar; 2(2):94-123. PubMed ID: 19777701
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-small cell lung cancer clinical practice guidelines in oncology.
    Ettinger DS; Bepler G; Bueno R; Chang A; Chang JY; Chirieac LR; D'Amico TA; Demmy TL; Feigenberg SJ; Grannis FW; Jahan T; Jahanzeb M; Kessinger A; Komaki R; Kris MG; Langer CJ; Le QT; Martins R; Otterson GA; Robert F; Sugarbaker DJ; Wood DE;
    J Natl Compr Canc Netw; 2006 Jul; 4(6):548-82. PubMed ID: 16813724
    [No Abstract]   [Full Text] [Related]  

  • 8. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy.
    Remon J; Soria JC; Peters S;
    Ann Oncol; 2021 Dec; 32(12):1637-1642. PubMed ID: 34481037
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    D'Addario G; Felip E;
    Ann Oncol; 2009 May; 20 Suppl 4():68-70. PubMed ID: 19454467
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
    Passiglia F; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S
    Crit Rev Oncol Hematol; 2020 Apr; 148():102862. PubMed ID: 32062311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
    García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
    Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    D'Addario G; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii39-40. PubMed ID: 18456762
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
    [No Abstract]   [Full Text] [Related]  

  • 15. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
    Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
    Felip E; Stahel RA; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Hendriks LE; Kerr KM; Menis J; Mok TS; Nestle U; Passaro A; Peters S; Planchard D; Smit EF; Solomon BJ; Veronesi G; Reck M;
    Ann Oncol; 2023 Apr; 34(4):339-357. PubMed ID: 36872130
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.